165:
In 2021, Delix was named one of the Fierce 15 of
Biotech. In 2022, Nature named Delix Spinout of the Year and Delix was awarded the Healthcare Businesswomen's Association (HBA) ACE award. In 2023, Delix was a finalist for the Prix Galien award for Best Startup and the BWB award for Biotech Innovation
455:
441:
694:
456:"The Galien Foundation Announces 2023 Prix Galien USA Nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and "Best Startup""
689:
586:
699:
157:
industry partnering program to screen psychoplastogens in models of substance use disorder. In 2021, the company expanded the leadership team, adding a new CEO, CSO, and CMO
709:
547:
290:
260:
714:
182:. Delix focuses on the development of non-hallucinogenic psychoplastogens as scalable alternatives to first-generation hallucinogenic psychoplastogens like
561:
342:
174:
To date, the company has synthesized over 2000 novel psychoplastogens. Many of these small molecule compounds are analogs of known psychedelics such as
498:
442:"Delix Therapeutics and Pfizer UK Recognized as Gender Equity Champions for Women in the Workplace by Healthcare Businesswomen's Association"
684:
704:
523:
154:
207:
118:
110:
366:
390:
198:
properties characteristic of other first-generation psychoplastogens. Two of the company’s known scaffolds are
78:
39:
320:
261:"Delix raises $ 70M to test psychedelic analogs for treating brain disorders in clinical trials next year"
587:"Industry Matters: Delix Therapeutics is taking Next-Gen psychedelics out of the lab and into the clinic"
315:
562:"A new psychedelics player emerges to treat mental health disorders — minus the hallucinogenic effects"
166:
of the Year and won the
Biotech Breakthrough Award for Neuroscience Therapeutics Company of the Year.
423:
149:
financing round, the largest in the space, to continue their work focused on neuroplastogens and
611:
660:
541:
415:
114:
650:
642:
407:
142:
219:
150:
145:
are highly potent neuroplasticity-promoting compounds. In
September 2021, Delix secured a
134:
106:
105:
is an
American biotech company based in Boston, Massachusetts. The company develops novel
402:
Garber, Ken (19 August 2022). "Delix
Therapeutics : psychedelics without the trip".
655:
630:
234:
224:
199:
191:
146:
122:
483:
678:
427:
44:
469:
411:
646:
391:
https://www.fiercebiotech.com/special-report/fierce-biotech-s-2021-fierce-15-0
187:
291:"Delix Therapeutics Pursues A Psychedelic-Inspired Medicine Without The Trip"
229:
203:
195:
179:
664:
419:
141:
at scale. David E. Olson founded the company following his discovery that
499:"U.S. Government Will Test Ibogaine Derivative As An Addiction Treatment"
183:
175:
138:
91:
343:"How Capital Markets Are Fueling Psychedelic Medicine Growth"
133:
The company was founded to develop novel, non-hallucinogenic
695:
Biotechnology companies established in the 21st century
631:"Engineering Safer Psychedelics for Treating Addiction"
367:"Shire neuro head lands at Delix Therapeutics as CEO"
153:
therapeutics. Also in Fall of 2021, Delix joined the
190:. Their compounds have been engineered to lack
86:
69:
61:
53:
32:
24:
137:, also known as neuroplastogens, to better treat
629:Peters, Jamie; Olson, David E (January 2021).
690:Pharmaceutical companies of the United States
8:
700:Biotechnology companies of the United States
524:"Chemists tame shamanic addiction treatment"
19:
612:"Can we take the high out of psychedelics?"
546:: CS1 maint: numeric names: authors list (
206:. Delix has licensed these compounds from
18:
654:
522:Andy Extance2020-12-17T14:30:00+00:00.
246:
710:American companies established in 2019
539:
316:"Harnessing Psychedelics for Healing"
121:(PTSD). It was co-founded in 2019 by
111:central nervous system (CNS) diseases
7:
715:2019 establishments in Massachusetts
284:
282:
280:
254:
252:
250:
341:Salarizadeh, Cynthia (2022-03-11).
314:Kathan, Jesse (December 13, 2021).
20:Delix Therapeutics, Inc. ("Delix")
14:
585:scientificinquirer (2022-03-14).
155:National Institute on Drug Abuse
119:post-traumatic stress disorder
1:
610:Brown, Grace (6 March 2021).
259:LaHucik, Kyle (2021-09-27).
109:-promoting therapeutics for
685:Biopharmaceutical companies
731:
412:10.1038/d41587-022-00006-0
705:Companies based in Boston
647:10.1177/26331055211033847
16:American biotech company
139:mental health disorders
79:Chief Executive Officer
635:Neuroscience Insights
65:Boston, Massachusetts
404:Nature Biotechnology
641:: 263310552110338.
591:Scientific Inquirer
321:Comstock's magazine
21:
470:"Award Categories"
170:Product Candidates
103:Delix Therapeutics
100:
99:
92:delixtherapeutics
722:
669:
668:
658:
626:
620:
619:
607:
601:
600:
598:
597:
582:
576:
575:
573:
572:
558:
552:
551:
545:
537:
535:
534:
519:
513:
512:
510:
509:
497:Yakowicz, Will.
494:
488:
487:
480:
474:
473:
466:
460:
459:
458:(Press release).
452:
446:
445:
444:(Press release).
438:
432:
431:
399:
393:
388:
382:
381:
379:
378:
363:
357:
356:
354:
353:
338:
332:
331:
329:
328:
311:
305:
304:
302:
301:
289:Yakowicz, Will.
286:
275:
274:
272:
271:
256:
135:psychoplastogens
96:
93:
82:
22:
730:
729:
725:
724:
723:
721:
720:
719:
675:
674:
673:
672:
628:
627:
623:
609:
608:
604:
595:
593:
584:
583:
579:
570:
568:
560:
559:
555:
538:
532:
530:
528:Chemistry World
521:
520:
516:
507:
505:
496:
495:
491:
482:
481:
477:
468:
467:
463:
454:
453:
449:
440:
439:
435:
401:
400:
396:
389:
385:
376:
374:
373:. 18 March 2021
365:
364:
360:
351:
349:
340:
339:
335:
326:
324:
313:
312:
308:
299:
297:
288:
287:
278:
269:
267:
258:
257:
248:
243:
220:Psychoplastogen
216:
196:psychostimulant
172:
163:
151:neuroplasticity
131:
129:Company History
125:and Nick Haft.
107:neuroplasticity
90:
76:
72:
49:
17:
12:
11:
5:
728:
726:
718:
717:
712:
707:
702:
697:
692:
687:
677:
676:
671:
670:
621:
602:
577:
566:Endpoints News
553:
514:
489:
484:"2023 Winners"
475:
461:
447:
433:
394:
383:
358:
333:
306:
276:
265:Fierce Biotech
245:
244:
242:
239:
238:
237:
235:David E. Olson
232:
227:
225:Tabernanthalog
222:
215:
212:
200:tabernanthalog
192:cardiotoxicity
171:
168:
162:
159:
130:
127:
123:David E. Olson
98:
97:
88:
84:
83:
73:
70:
67:
66:
63:
59:
58:
55:
51:
50:
48:
47:
42:
40:Pharmaceutical
36:
34:
30:
29:
26:
15:
13:
10:
9:
6:
4:
3:
2:
727:
716:
713:
711:
708:
706:
703:
701:
698:
696:
693:
691:
688:
686:
683:
682:
680:
666:
662:
657:
652:
648:
644:
640:
636:
632:
625:
622:
617:
613:
606:
603:
592:
588:
581:
578:
567:
563:
557:
554:
549:
543:
529:
525:
518:
515:
504:
500:
493:
490:
485:
479:
476:
471:
465:
462:
457:
451:
448:
443:
437:
434:
429:
425:
421:
417:
413:
409:
405:
398:
395:
392:
387:
384:
372:
371:FierceBiotech
368:
362:
359:
348:
347:Rolling Stone
344:
337:
334:
323:
322:
317:
310:
307:
296:
292:
285:
283:
281:
277:
266:
262:
255:
253:
251:
247:
240:
236:
233:
231:
228:
226:
223:
221:
218:
217:
213:
211:
209:
205:
201:
197:
193:
189:
185:
181:
177:
169:
167:
160:
158:
156:
152:
148:
144:
140:
136:
128:
126:
124:
120:
116:
112:
108:
104:
95:
89:
85:
80:
74:
68:
64:
60:
56:
52:
46:
45:Biotechnology
43:
41:
38:
37:
35:
31:
27:
23:
638:
634:
624:
615:
605:
594:. Retrieved
590:
580:
569:. Retrieved
565:
556:
531:. Retrieved
527:
517:
506:. Retrieved
502:
492:
478:
464:
450:
436:
403:
397:
386:
375:. Retrieved
370:
361:
350:. Retrieved
346:
336:
325:. Retrieved
319:
309:
298:. Retrieved
294:
268:. Retrieved
264:
173:
164:
143:psychedelics
132:
102:
101:
62:Headquarters
25:Company type
679:Categories
596:2022-06-07
571:2022-06-07
533:2022-06-08
508:2022-06-08
377:2021-08-27
352:2022-06-08
327:2022-06-08
300:2022-05-18
270:2022-06-08
241:References
188:psilocybin
115:depression
71:Key people
428:251694020
230:AAZ-A-154
204:AAZ-A-154
180:5-MeO-DMT
75:Mark Rus
665:34350400
616:Wired UK
542:cite web
420:35986098
214:See also
208:UC Davis
184:ketamine
176:ibogaine
147:Series A
113:such as
33:Industry
656:8295933
87:Website
54:Founded
28:Private
663:
653:
503:Forbes
426:
418:
295:Forbes
161:Awards
424:S2CID
661:PMID
548:link
416:PMID
202:and
194:and
186:and
178:and
117:and
94:.com
57:2019
651:PMC
643:doi
408:doi
681::
659:.
649:.
639:16
637:.
633:.
614:.
589:.
564:.
544:}}
540:{{
526:.
501:.
422:.
414:.
406:.
369:.
345:.
318:.
293:.
279:^
263:.
249:^
210:.
667:.
645::
618:.
599:.
574:.
550:)
536:.
511:.
486:.
472:.
430:.
410::
380:.
355:.
330:.
303:.
273:.
81:)
77:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.